HEADER GENE REGULATION 14-JAN-21 7LEL
TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN (BD2) OF HUMAN BRDT BOUND
TITLE 2 TO BROMOSPORINE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BROMODOMAIN TESTIS-SPECIFIC PROTEIN;
COMPND 3 CHAIN: A, B, C, D;
COMPND 4 SYNONYM: CANCER/TESTIS ANTIGEN 9,CT9,RING3-LIKE PROTEIN;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BRDT;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS BRDT, BET, PLK1, TESTIS SPECIFIC, BROMODOMAIN, GENE REGULATION
EXPDTA X-RAY DIFFRACTION
AUTHOR A.CHAN,M.R.KARIM,E.SCHONBRUNN
REVDAT 5 25-DEC-24 7LEL 1 REMARK LINK
REVDAT 4 18-OCT-23 7LEL 1 REMARK
REVDAT 3 24-NOV-21 7LEL 1 JRNL
REVDAT 2 17-NOV-21 7LEL 1 JRNL
REVDAT 1 14-JUL-21 7LEL 0
JRNL AUTH R.M.KARIM,M.J.BIKOWITZ,A.CHAN,J.Y.ZHU,D.GRASSIE,A.BECKER,
JRNL AUTH 2 N.BERNDT,S.GUNAWAN,N.J.LAWRENCE,E.SCHONBRUNN
JRNL TITL DIFFERENTIAL BET BROMODOMAIN INHIBITION BY
JRNL TITL 2 DIHYDROPTERIDINONE AND PYRIMIDODIAZEPINONE KINASE
JRNL TITL 3 INHIBITORS.
JRNL REF J.MED.CHEM. V. 64 15772 2021
JRNL REFN ISSN 0022-2623
JRNL PMID 34710325
JRNL DOI 10.1021/ACS.JMEDCHEM.1C01096
REMARK 2
REMARK 2 RESOLUTION. 2.15 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.13_2998
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.20
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4
REMARK 3 NUMBER OF REFLECTIONS : 28670
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.185
REMARK 3 R VALUE (WORKING SET) : 0.183
REMARK 3 FREE R VALUE : 0.232
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.500
REMARK 3 FREE R VALUE TEST SET COUNT : 1004
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 56.1990 - 4.1124 0.97 4000 146 0.1472 0.1651
REMARK 3 2 4.1124 - 3.2642 0.97 4013 145 0.1655 0.2284
REMARK 3 3 3.2642 - 2.8516 0.97 4013 146 0.2056 0.2801
REMARK 3 4 2.8516 - 2.5909 0.96 3964 144 0.2096 0.2273
REMARK 3 5 2.5909 - 2.4052 0.95 3902 141 0.2157 0.2948
REMARK 3 6 2.4052 - 2.2634 0.94 3885 141 0.2212 0.2967
REMARK 3 7 2.2634 - 2.1500 0.94 3889 141 0.2360 0.3223
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.820
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 29.99
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.28
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : NULL NULL
REMARK 3 ANGLE : NULL NULL
REMARK 3 CHIRALITY : NULL NULL
REMARK 3 PLANARITY : NULL NULL
REMARK 3 DIHEDRAL : NULL NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): -25.9313 -7.2059 -38.2494
REMARK 3 T TENSOR
REMARK 3 T11: 0.2333 T22: 0.2396
REMARK 3 T33: 0.2455 T12: 0.0105
REMARK 3 T13: 0.0051 T23: -0.0030
REMARK 3 L TENSOR
REMARK 3 L11: 0.5075 L22: 0.3010
REMARK 3 L33: 0.4058 L12: 0.0359
REMARK 3 L13: 0.1850 L23: -0.3261
REMARK 3 S TENSOR
REMARK 3 S11: 0.0053 S12: 0.0066 S13: 0.0100
REMARK 3 S21: -0.0147 S22: 0.0085 S23: 0.0060
REMARK 3 S31: 0.0125 S32: -0.0142 S33: -0.0176
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7LEL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-21.
REMARK 100 THE DEPOSITION ID IS D_1000253741.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 21-APR-19
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 22-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9700
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28678
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150
REMARK 200 RESOLUTION RANGE LOW (A) : 56.199
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3
REMARK 200 DATA REDUNDANCY : 3.849
REMARK 200 R MERGE (I) : 0.08500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.7700
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7
REMARK 200 DATA REDUNDANCY IN SHELL : 3.87
REMARK 200 R MERGE FOR SHELL (I) : 0.58500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.740
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 5VBQ
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.69
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M CACL2, 2H2O, 0.1 M BIS-TRIS (PH
REMARK 280 6.5), AND 30 % V/V PEG MME 550, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3, 4
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 4
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 262
REMARK 465 ALA A 263
REMARK 465 ALA A 264
REMARK 465 GLY B 262
REMARK 465 ALA B 263
REMARK 465 ALA B 264
REMARK 465 GLY C 262
REMARK 465 ALA C 263
REMARK 465 ALA C 264
REMARK 465 GLY D 262
REMARK 465 ALA D 263
REMARK 465 ALA D 264
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 ND2 ASN D 297 C06 BMF D 401 1.45
REMARK 500 OE2 GLU A 271 O HOH A 501 2.11
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR B 266 134.33 78.59
REMARK 500
REMARK 500 REMARK: NULL
DBREF 7LEL A 266 378 UNP Q58F21 BRDT_HUMAN 266 378
DBREF 7LEL B 266 378 UNP Q58F21 BRDT_HUMAN 266 378
DBREF 7LEL C 266 378 UNP Q58F21 BRDT_HUMAN 266 378
DBREF 7LEL D 266 378 UNP Q58F21 BRDT_HUMAN 266 378
SEQADV 7LEL GLY A 262 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA A 263 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA A 264 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL SER A 265 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL GLY B 262 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA B 263 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA B 264 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL SER B 265 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL GLY C 262 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA C 263 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA C 264 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL SER C 265 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL GLY D 262 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA D 263 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL ALA D 264 UNP Q58F21 EXPRESSION TAG
SEQADV 7LEL SER D 265 UNP Q58F21 EXPRESSION TAG
SEQRES 1 A 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG
SEQRES 2 A 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS
SEQRES 3 A 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP
SEQRES 4 A 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL
SEQRES 5 A 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET
SEQRES 6 A 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA
SEQRES 7 A 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN
SEQRES 8 A 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU
SEQRES 9 A 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE
SEQRES 1 B 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG
SEQRES 2 B 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS
SEQRES 3 B 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP
SEQRES 4 B 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL
SEQRES 5 B 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET
SEQRES 6 B 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA
SEQRES 7 B 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN
SEQRES 8 B 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU
SEQRES 9 B 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE
SEQRES 1 C 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG
SEQRES 2 C 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS
SEQRES 3 C 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP
SEQRES 4 C 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL
SEQRES 5 C 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET
SEQRES 6 C 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA
SEQRES 7 C 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN
SEQRES 8 C 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU
SEQRES 9 C 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE
SEQRES 1 D 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG
SEQRES 2 D 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS
SEQRES 3 D 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP
SEQRES 4 D 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL
SEQRES 5 D 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET
SEQRES 6 D 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA
SEQRES 7 D 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN
SEQRES 8 D 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU
SEQRES 9 D 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE
HET BMF A 401 28
HET BMF B 401 28
HET BMF C 401 28
HET BMF D 401 28
HETNAM BMF BROMOSPORINE
HETSYN BMF ETHYL (3-METHYL-6-{4-METHYL-3-[(METHYLSULFONYL)
HETSYN 2 BMF AMINO]PHENYL}[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-8-YL)
HETSYN 3 BMF CARBAMATE
FORMUL 5 BMF 4(C17 H20 N6 O4 S)
FORMUL 9 HOH *98(H2 O)
HELIX 1 AA1 THR A 266 LEU A 284 1 19
HELIX 2 AA2 ALA A 285 LYS A 287 5 3
HELIX 3 AA3 HIS A 288 TRP A 293 1 6
HELIX 4 AA4 PRO A 294 TYR A 296 5 3
HELIX 5 AA5 ASP A 300 GLY A 305 1 6
HELIX 6 AA6 ASN A 308 VAL A 313 1 6
HELIX 7 AA7 ASP A 318 ASN A 328 1 11
HELIX 8 AA8 ASP A 333 ASN A 352 1 20
HELIX 9 AA9 HIS A 356 SER A 374 1 19
HELIX 10 AB1 THR B 266 LEU B 284 1 19
HELIX 11 AB2 ALA B 285 LYS B 287 5 3
HELIX 12 AB3 HIS B 288 TRP B 293 1 6
HELIX 13 AB4 PRO B 294 TYR B 296 5 3
HELIX 14 AB5 ASP B 300 GLY B 305 1 6
HELIX 15 AB6 ASN B 308 VAL B 313 1 6
HELIX 16 AB7 ASP B 318 ASN B 328 1 11
HELIX 17 AB8 ASP B 333 ASN B 352 1 20
HELIX 18 AB9 HIS B 356 SER B 374 1 19
HELIX 19 AC1 THR C 266 LEU C 284 1 19
HELIX 20 AC2 ALA C 285 LYS C 287 5 3
HELIX 21 AC3 HIS C 288 TRP C 293 1 6
HELIX 22 AC4 PRO C 294 TYR C 296 5 3
HELIX 23 AC5 ASP C 300 GLY C 305 1 6
HELIX 24 AC6 ASN C 308 VAL C 313 1 6
HELIX 25 AC7 ASP C 318 ASN C 328 1 11
HELIX 26 AC8 ASP C 333 ASN C 352 1 20
HELIX 27 AC9 HIS C 356 SER C 374 1 19
HELIX 28 AD1 THR D 266 ALA D 285 1 20
HELIX 29 AD2 HIS D 288 TRP D 293 1 6
HELIX 30 AD3 PRO D 294 TYR D 296 5 3
HELIX 31 AD4 ASP D 300 GLY D 305 1 6
HELIX 32 AD5 ASN D 308 VAL D 313 1 6
HELIX 33 AD6 ASP D 318 ASN D 328 1 11
HELIX 34 AD7 ASP D 333 ASN D 352 1 20
HELIX 35 AD8 HIS D 356 SER D 374 1 19
CRYST1 45.990 58.460 60.770 72.58 71.28 70.62 P 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021744 -0.007650 -0.005855 0.00000
SCALE2 0.000000 0.018133 -0.004008 0.00000
SCALE3 0.000000 0.000000 0.017794 0.00000